“…However, it should be noted that adding recombinant Vam7 to in vitro fusion reactions can bypass blocks in fusion that occur prior to docking and trans-SNARE pairing. 10,17,90,91 Thus, it is possible that Ycf1 serves a second function during fusion that is linked to transport activity prior to docking. Because the in vitro fusion assay is devoid of toxic levels of Cd 2C and other soluble substrates, or glutathione S-transferase for that matter, we must suppose that Ycf1 carries out a novel ATPase dependent function.…”